RE: Boom! Shore Cap have a 12 month target of £2.08!4 Oct 2023 07:33
Surely that is conservative? It values the company at just £400m? In bio Pharma diagnostic terms that really is peanuts for a company who, by that stage, should be selling millions of tests pa.
Don’t forget a patient who currently undergoes a biopsy - this can only be done ONCE. A single point in time. That is the ‘current’ reality. With Episwitch PSE the test can be repeated whenever thought to be required to keep ongoing monitoring/maintenance.
That will be the ‘new’ much improved reality.
I think £2.08 in 12 months time is very very conservative indeed.